Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.

Rizzoli, R; Greenspan, S L; Bone, G; Schnitzer, T J; Watts, N B; Adami, S; Foldes, A J; Roux, C; Levine, M A; Uebelhart, B; Santora, A C; Kaur, A; Peverly, C A; Orloff, J J

Rizzoli, R; Greenspan, S L; Bone, G; Schnitzer, T J; Watts, N B; Adami, S; Foldes, A J; Roux, C; Levine, M A; Uebelhart, B; Santora, A C; Kaur, A; Peverly, C A; Orloff, J J.

Affiliation

Rizzoli R; Department of Internal Medicine, Hõpital Cantonal, Geneva, Switzerland.

J Bone Miner Res ; 17(11): 1988-96, 2002 Nov.

Article de En | MEDLINE | ID: mdl-12412806

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ostéoporose post-ménopausique / Alendronate Type d'étude: Clinical_trials / Etiology_studies Limites: Adult / Aged / Aged80 / Female / Humans / Middle aged Langue: En Journal: J Bone Miner Res Sujet du journal: METABOLISMO / ORTOPEDIA Année: 2002 Type de document: Article Pays d'affiliation: Suisse

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links